---
canonical_url: https://www.stockexpertai.com/earnings/pnc
last_updated: 2026-07-18T06:16:46.825Z
---

# The PNC Financial Services Group, Inc. (PNC) Q1 FY2027 Earnings Preview

> This content was automatically generated with FMP live data + Q2 FY2026 earnings call transcript. Generated: 2026-07-18T06:16:45.552Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $252.86 (▼ -0.92%) | fmp:quote |
| Market Cap | $101.5B | fmp:profile |
| 52w range | $176.88 – $256.49 | fmp:quote |
| Earnings | Thu 15 Oct | fmp:earnings-history |
| EPS estimate | $4.93 (+13% YoY) | fmp:earnings-estimate |
| Revenue estimate | $6.6B | fmp:earnings-estimate |
| Beat streak | 8/4 | fmp:earnings-history |
| Rating | B (overall 3/5) | fmp:ratings |
| Analyst median target | $280 (+10.7% upside) | fmp:price-target-consensus |
| MoonshotScore | 49/100 | derived |
| Council | 3/6 bullish | derived |
| Munger verdict | Fairly Valued | derived |

## The PNC Financial Services Group, Inc. — Q1 FY2027 Expectations

Q1 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$6.6B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$4.93</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 8 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** B · **Stance:** HOLD · **Council:** 3/6 · **Moonshot:** 49

= MoonshotScore <strong>49</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="multi-pillar formula">[multi-pillar formula]</sup> + Council <strong>3/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (0 metrics)

—

## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 0.0 | weak | Q2 vs Q3: growth negative (-21.8%, contraction) |
| Gross Margin | 10.0 | strong | Q2: very high margin (97.2%, software/cloud territory) |
| Operating Leverage | 4.0 | medium | op margin very strong (37.6%, scale leverage) |
| Cash Runway | 3.0 | weak | FCF very strong ($1.9B, 1928000000.0× CapEx) |
| R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) |
| Price Momentum | 7.0 | strong | RSI 63.2 positive momentum, 50d above |
| News Sentiment | 7.0 | strong | strong buy consensus (73%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | bull | macro · target upside +10.7% |
| Ken Griffin | bull | flow · 50d MA above |
| Jim Simons | neutral | quant · RSI 63 |
| Klarman | neutral | value · target upside +10.7% |
| Buffett | bull | quality · ROE score 4/5 |
| Munger | neutral | valuation · target upside +10.7% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Fairly Valued
- **Financial Health:** Moderate
- **Margin of Safety:** Moderate
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Healthy

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 63.2 — yükselişte nötr — overbought sınırının altında, momentum pozitif
- **50d MA:** $232 — hisse %8.9 üstünde — kısa vadeli destek
- **200d MA:** $214 — hisse %18.3 üstünde — uzun vadeli destek
- **Volume (10d):** -22%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q3 FY25 | $4.35 | $4.05 | BEAT | -2.2% |
| Q4 FY25 | $4.88 | $4.23 | BEAT | -1.0% |
| Q1 FY26 | $4.13 | $3.93 | BEAT | -0.9% |
| Q2 FY26 | $4.85 | $4.46 | +8.7% EPS | +0.4% |

Q2 (July 15, 2026): EPS $4.85 vs $4.46 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +8.7% beat. D+1 movement: +0.4%<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q1 EPS > $4.93 + CapEx discipline**

Threshold: EPS > $4.93<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $280<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $305<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $4.93 + CapEx < $0**

Threshold: EPS ≈ $4.93<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $0<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $253<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $280<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $4.78 or CapEx ≥ $0**

Threshold: EPS < $4.78<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $253 below SMA200 $214<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $182<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q2: EPS $4.85 vs $4.46 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock +0.4% D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q2 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q2 FY26

### CapEx shock
Q2 CapEx $0<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q2 op margin 37.6%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q1 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $280 (+10.7% upside vs current $253)
- **High / Low:** $305 / $257
- **Buy / Hold / Sell:** 16 / 6 / 0
- **Analyst count:** 15 (last quarter), 81 all-time

## Additional Transcript Insights

—

---

*Data source: FMP (live query, 2026-07-18), Q2 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*